James Hamilton

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Circulating Tumor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Yuanqing Ma, Allison Joyce, Olivia Brandenburg, Faeze Saatchi, Christina Stevens, Vanina Toffessi Tcheuyap, Alana Christie, Quyen N Do, Oluwatomilade Fatunde, Alyssa Macchiaroli, So C Wong, Layton Woolford, Qurratulain Yousuf, Jeffrey Miyata, Deyssy Carrillo, Oreoluwa Onabolu, Tiffani McKenzie, Akhilesh Mishra, Tanner Hardy, Wei He, Daniel Li, Alexander Ivanishev, Yang Zhang, Ivan Pedrosa, Payal Kapur, Thomas Schluep, Steven B Kanner, James Hamilton, James Brugarolas
HIF2 inactivation and tumor suppression with a tumor-directed RNA-silencing drug in mice and humans. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Christine I Wooddell, Man-Fung Yuen, Henry Lik-Yuen Chan, Robert G Gish, Stephen A Locarnini, Deborah Chavez, Carlo Ferrari, Bruce D Given, James Hamilton, Steven B Kanner, Ching-Lung Lai, Johnson Y N Lau, Thomas Schluep, Zhao Xu, Robert E Lanford, David L Lewis
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg. Science translational medicine 9 (409) (2018)